Neuraxis, Inc. (NRXS) is a publicly traded Healthcare sector company. As of November 9, 2026, NRXS trades at $5.76 with a market cap of $78.36M and a P/E ratio of -7.28. NRXS moved -1.44% today. Year to date, NRXS is +39.91%; over the trailing twelve months it is +146.64%. Its 52-week range spans $1.33 to $9.33. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces NRXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NRXS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.76 |
| Market Cap | $78.36M |
| P/E Ratio | -7.28 |
| EPS | $-0.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.33 |
| 52-Week Low | $1.33 |
| Volume | 31.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.57M |
| Net Income | $-7.80M |
| Gross Margin | 84.23% |
1 analysts cover NRXS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.